An engineered IL-2 partial agonist promotes CD8+ T cell stemness.
Nature. 2021 Sep;597(7877):544-548. doi: 10.1038/s41586-021-03861-0. Epub 2021 Sep 15.
Nature. 2021.
PMID: 34526724
Free PMC article.